ProfileGDS5678 / 1454627_a_at
TitleAnti-VEGF and Anti-Notch treatment effect on U87 glioblastoma xenograft tumors [Mouse430_2]
OrganismMus musculus


control bevacizumab dibenzazepine GSM967852 GSM967853 GSM967854 GSM967855 GSM967856 GSM967862 GSM967863 GSM967864 GSM967865 GSM967857 GSM967858 GSM967859 GSM967860 GSM967861 99% 99% 99% 99% 99% 99% 99% 99% 99% 99% 99% 99% 99% 99% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM967852U87-EV human glioblastoma xenograft - Control 111.791599
GSM967853U87-EV human glioblastoma xenograft - Control 211.780199
GSM967854U87-EV human glioblastoma xenograft - Control 311.828799
GSM967855U87-EV human glioblastoma xenograft - Control 411.979999
GSM967856U87-EV human glioblastoma xenograft - Control 512.03299
GSM967862U87-EV human glioblastoma xenograft - Bevacizumab treated 111.488299
GSM967863U87-EV human glioblastoma xenograft - Bevacizumab treated 211.271799
GSM967864U87-EV human glioblastoma xenograft - Bevacizumab treated 311.924299
GSM967865U87-EV human glioblastoma xenograft - Bevacizumab treated 412.061999
GSM967857U87-EV human glioblastoma xenograft - dibenzazepine treated 111.784999
GSM967858U87-EV human glioblastoma xenograft - dibenzazepine treated 211.77799
GSM967859U87-EV human glioblastoma xenograft - dibenzazepine treated 311.975999
GSM967860U87-EV human glioblastoma xenograft - dibenzazepine treated 412.01899
GSM967861U87-EV human glioblastoma xenograft - dibenzazepine treated 512.189899